Amylyx Pharmaceuticals Inc (AMLX)
2.03
+0.03
(+1.50%)
USD |
NASDAQ |
May 03, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Accounts Payable (Quarterly): 22.06M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.06M |
| September 30, 2023 | 6.371M |
| June 30, 2023 | 24.70M |
| March 31, 2023 | 10.77M |
| December 31, 2022 | 6.257M |
| September 30, 2022 | 7.052M |
| Date | Value |
|---|---|
| June 30, 2022 | 8.117M |
| March 31, 2022 | 10.04M |
| December 31, 2021 | 4.372M |
| September 30, 2021 | 3.026M |
| December 31, 2020 | 3.613M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.026M
Minimum
Sep 2021
24.70M
Maximum
Jun 2023
9.671M
Average
7.052M
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
| Cassava Sciences Inc | 10.57M |
| iRhythm Technologies Inc | 5.543M |
| Bristol-Myers Squibb Co | 3.539B |
| Moderna Inc | 183.00M |
| ACADIA Pharmaceuticals Inc | 17.54M |